Skip to main content
SpringerLink
Log in

Langerhans cell histiocytosis in adults: a retrospective, single-center case series

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Langerhans cell histiocytosis is rare in adults, and most of what we know about its diagnosis and treatment comes from pediatric studies. We report clinical findings and results of treatment in a retrospective series of 63 consecutive adult patients (18–76 years old), treated at our pediatric unit from 1990 to 2020 using the same approach as for children. Patients were classified as having single-system disease (SS-LCH) in 41 cases, which was unifocal in 34 of them and multifocal in 7, or multisystem disease (MS-LCH) in 17 and primary pulmonary (pLCH) in 5. Twenty patients also had diabetes insipidus. A “wait and see” strategy was recommended after biopsy/surgery for patients with unifocal SS-LCH. Systemic treatment was proposed for cases of SS-LCH involving “special sites” or with multifocal disease, and in cases of MS-LCH. EFS and OS for the cohort as a whole were 62.2% and 100%, respectively, at 5 years and 52.5% and 97.6% at 10 years. Three patients died due to the damage caused by the multiple therapies administered. The rate of disease reactivation was high (affecting 40% of cases), with several reactivations over the years despite multiple lines of treatment. Though clinical history of LCH may differ between adults and children, in the absence of specific, tailored protocols, clinical approach to adult cases may draw on pediatric experience. Patients with limited disease have a good prognosis without any need for systemic therapy. Potentially greater toxicity in adults of systemic treatments generally used in pediatric setting should be borne in mind.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aricò M, Weitzman S (2012) The histiocytosis. In: Stevens MCG, Caron HN, Biondi A (eds). Cancer in children: clinical management. Oxford, UK: Oxford University Press 230-239

  2. Rodriguez-Galindo C, Allen CE (2020) Langerhans cell histiocytosis. Blood 135(16):1319–1331

    Article  Google Scholar 

  3. Collin M, Bigley V, McClain KL et al (2015) Cell(s) of origin of Langerhans cell histiocytosis. Hematol Oncol Clin North Am 29(5):825–838

    Article  Google Scholar 

  4. Berres ML, Lim KP, Peters T et al (2014) BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med 211(4):669–683

    Article  CAS  Google Scholar 

  5. Hogstad B, Berres ML, Chakraborty R et al (2018) RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med 215(1):319–336

    Article  CAS  Google Scholar 

  6. Alston RD, Tatevossian RG, McNally RJ et al (2007) Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Pediatr Blood Cancer 48(5):555–560

    Article  CAS  Google Scholar 

  7. Guyot-Goubin A, Donadieu J, Barkaoui M et al (2008) Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004. Pediatr Blood Cancer 51(1):71–75

    Article  Google Scholar 

  8. Salotti JA, Nanduri V, Pearce MS et al (2009) Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child 94(5):376–380

    Article  CAS  Google Scholar 

  9. Stålemark H, Laurencikas E, Karis J et al (2008) Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer 51(1):76–81

    Article  Google Scholar 

  10. Goyal G, Shah MV, Hook CC et al (2018) Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long-term outcomes. Br J Haematol 182(4):579–581

    Article  Google Scholar 

  11. Baumgartner I, von Hochstetter A, Baumert B et al (1997) Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol 28(1):9–14

    Article  CAS  Google Scholar 

  12. Allen CE, Merad M, McClain KL (2018) Langerhans cell histiocytosis. N Engl J Med 379(9):856–868

    Article  CAS  Google Scholar 

  13. Donadieu J, Egeler RM, Pritchard J (2005) Langerhans cell histiocytosis: a clinical update. In: Weitzman S, Egeler RM (eds) Histiocytic disorders of children and adults. Cambridge University Press, Cambridge, pp 95–129

    Chapter  Google Scholar 

  14. Tazi A, de Margerie C, Naccache JM et al (2015) The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis 10(1):30

    Article  Google Scholar 

  15. De Martino E, Go RS, Vassallo R (2016) Langerhans cell histiocytosis and other histiocytic diseases of the lung. Clin Chest Med 37(3):421–430

    Article  Google Scholar 

  16. Girschikofsky M, Arico M, Castillo D et al (2013) Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net. Orphanet J Rare Dis 8:72

    Article  Google Scholar 

  17. Cantu MA, et al (2012) Optimal therapy for adults with Langerhans cell histiocytosis bone lesions. PLoS One 7(8):e43257.

  18. Haupt R, Nanduri V, Calevo MG et al (2004) Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer 42(5):438–444

    Article  Google Scholar 

  19. Ma J, Laird JH, Chau KW et al (2019) Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies. Cancer Med 8(1):58–66

    Article  Google Scholar 

  20. Broadbent V, Gadner H, Komp DM et al (1989) Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society. Med Pediatr Oncol 17:92–495

    Article  Google Scholar 

  21. Phillips M, Allen C, Gerson P et al (2009) Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 52(1):97–101

    Article  Google Scholar 

  22. Kaplan E, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53:457–481

    Article  Google Scholar 

  23. Conover WJ (1980) Practical nonparametric statistics. John Wiley & Sons, New York, pp 153–169

    Google Scholar 

  24. Cox DR (1972) Regression models and life tables. J R Stat SocB 34:187–220

    Google Scholar 

  25. Aricò M, Girschikofsky M, Généreau T et al (2003) Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 39(16):2341–8

    Article  Google Scholar 

  26. Grois N, Pötschger U, Prosch H et al (2006) DALHX- and LCH I and II Study Committee. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer 46(2):228–33

    Article  CAS  Google Scholar 

  27. Kaltsas GA et al (2000) Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 85(4):1370–1376

    Article  CAS  Google Scholar 

  28. Tazi A (2006) Adult pulmonary Langerhans’ cell histiocytosis. Eur Respir J 27(6):1272–1285

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Oncology Unit, Medical Oncology and Hematology Department, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, 20133, Milano, MI, Italy

    Stefano Chiaravalli, Andrea Ferrari, Luca Bergamaschi, Nadia Puma, Giovanna Gattuso, Giovanna Sironi, Olga Nigro, Virginia Livellara, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Cristina Meazza, Filippo Spreafico, Michela Casanova, Monica Terenziani, Roberto Luksch & Maura Massimino

Authors
  1. Stefano Chiaravalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Ferrari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luca Bergamaschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nadia Puma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanna Gattuso
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giovanna Sironi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Olga Nigro
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Virginia Livellara
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Elisabetta Schiavello
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Veronica Biassoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Marta Podda
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Cristina Meazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Filippo Spreafico
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Michela Casanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Monica Terenziani
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Roberto Luksch
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Maura Massimino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stefano Chiaravalli.

Ethics declarations

Conflict of interest

The authors declare that have no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chiaravalli, S., Ferrari, A., Bergamaschi, L. et al. Langerhans cell histiocytosis in adults: a retrospective, single-center case series. Ann Hematol 101, 265–272 (2022). https://doi.org/10.1007/s00277-021-04694-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04694-7

Keywords

Search

Navigation